Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Influence of nano‐hydroxyapatite coating implants on gene expression of osteogenic markers and micro‐CT parameters. An in vivo study in diabetic rats

2020; Wiley; Volume: 109; Issue: 5 Linguagem: Inglês

10.1002/jbm.a.37052

1552-4965

Paula Gabriela Faciola Pessôa de Oliveira, Mariana Sales de Melo Soares, Adriana Maria Mariano Silveira e Souza, Mário Taba, Daniela Bazan Palioto, Michel Reis Messora, Bruna Ghiraldini, Felipe Anderson Nunes, Sérgio Luı́s Scombatti de Souza,

Bone and Dental Protein Studies

Abstract This study evaluated the response of a nano‐hydroxyapatite coating implant through gene expression analysis (runt‐related transcription factor 2 (Runx2), alkaline phosphatase (Alp), osteopontin (Opn), osteocalcin (Oc), receptor activator of nuclear factor‐kappa B (Rank), receptor activator of nuclear factor‐kappa B ligand (Rank‐L), and osteoprotegerin (Opg)). Three‐dimensional evaluation (percent bone volume (BV/TV); percent intersection surface (BIC); bone surface/volume ratio (BS/BV); and total porosity (To.Po)) were also analyzed. Mini implants were surgically placed in tibias of both healthy and diabetic rats. The animals were euthanized at 7 and 30 days. Evaluating all factors the relative expression of Rank showed that NANO surface presented the best results at 7 days (diabetic rats). Furthermore the levels of Runx2, Alp, Oc, and Opn suggest an increase in osteoblasts proliferation, especially in early stages of osseointegration. %BIC in healthy and diabetic (7 days) depicted statistically significant differences for NANO group. BV/TV, BS/BV and To.Po demonstrated higher values for NANO group in all evaluated time point and irrespective of systemic condition, but BS/BV 30 days (healthy rat) and 7 and 30 days (diabetic rat). Microtomographic and gene expression analyses have shown the benefits of nano‐hydroxyapatite coated implants in promoting new bone formation in diabetic rats.